kabutan

Linical Co., Ltd.(2183) Summary

2183
TSE Standard
Linical Co., Ltd.
310
JPY
0
(0.00%)
Mar 13, 3:30 pm JST
1.94
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
1.24
Yield
5.16%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
310 JPY 1.94 USD
Previous Close Mar 12
310 JPY 1.95 USD
High Mar 13, 12:52 pm
312 JPY 1.95 USD
Low Mar 13, 2:28 pm
309 JPY 1.93 USD
Volume
23,800
Trading Value
7.00M JPY 0.05M USD
VWAP
310.59 JPY 1.95 USD
Minimum Trading Value
31,000 JPY 194 USD
Market Cap
7.67B JPY 0.05B USD
Number of Trades
51
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
54
1-Year High Nov 17, 2025
252
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 166,400
Feb 27, 2026 0 178,100
Feb 20, 2026 0 174,300
Feb 13, 2026 0 166,700
Feb 6, 2026 0 212,500
Company Profile
Linical Co., Ltd. specializes in contract research for pharmaceutical development, focusing on Phase II and III clinical trials. The company also provides support for pharmaceutical sales.
Sector
Services
Linical Co., Ltd. primarily engages in Contract Research Organization (CRO) services for pharmaceutical development, while also offering post-marketing support services for pharmaceuticals. In its CRO business, the company undertakes various tasks including clinical trial monitoring, quality control, data management, statistical analysis, and medical writing for documents such as clinical trial protocols. Additionally, Linical provides drug discovery support services, offering consulting on development strategy planning, regulatory affairs, and approval applications for biotech venture companies. In its post-marketing support business, Linical handles planning, monitoring, and auditing services. Through these operations, Linical offers comprehensive global services spanning from drug discovery support to clinical development, and post-approval lifecycle management, including post-marketing clinical trials and research.